The global market for Contract Pharmaceutical Manufacturing was estimated to be worth US$ 87350 million in 2023 and is forecast to a readjusted size of US$ 131100 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030

Contract Pharmaceutical Manufacturing - Market

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.

North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.

In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contract Pharmaceutical Manufacturing by region & country, by Type, and by Application.

The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.

Market Segmentation

Scope of Contract Pharmaceutical Manufacturing - Market Report

Report Metric	Details
Report Name	Contract Pharmaceutical Manufacturing - Market
Forecasted market size in 2030	US$ 131100 million
CAGR	5.9%
Forecasted years	2024 - 2030
Segment by Type:	Oral Injectable API Other
Segment by Application	Large Enterprise Small Medium Enterprise
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Contract Pharmaceutical Manufacturing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Contract Pharmaceutical Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Contract Pharmaceutical Manufacturing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Contract Pharmaceutical Manufacturing - Market size in 2030?

Ans: The Contract Pharmaceutical Manufacturing - Market size in 2030 will be US$ 131100 million.

What is the market share of major companies in Contract Pharmaceutical Manufacturing - Market?

Ans: Global top five players hold a share about 10%.

What is the Contract Pharmaceutical Manufacturing - Market share by type?

Ans: In terms of product, API is the largest segment, with a share about 75%.

Who are the main players in the Contract Pharmaceutical Manufacturing - Market report?

Ans: The main players in the Contract Pharmaceutical Manufacturing - Market are Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica

What are the Application segmentation covered in the Contract Pharmaceutical Manufacturing - Market report?

Ans: The Applications covered in the Contract Pharmaceutical Manufacturing - Market report are Large Enterprise, Small Medium Enterprise

What are the Type segmentation covered in the Contract Pharmaceutical Manufacturing - Market report?

Ans: The Types covered in the Contract Pharmaceutical Manufacturing - Market report are Oral, Injectable, API, Other

1 Market Overview

1.1 Contract Pharmaceutical Manufacturing Product Introduction

1.2 Global Contract Pharmaceutical Manufacturing Market Size Forecast

1.3 Contract Pharmaceutical Manufacturing Market Trends & Drivers

1.3.1 Contract Pharmaceutical Manufacturing Industry Trends

1.3.2 Contract Pharmaceutical Manufacturing Market Drivers & Opportunity

1.3.3 Contract Pharmaceutical Manufacturing Market Challenges

1.3.4 Contract Pharmaceutical Manufacturing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Contract Pharmaceutical Manufacturing Players Revenue Ranking (2023)

2.2 Global Contract Pharmaceutical Manufacturing Revenue by Company (2019-2024)

2.3 Key Companies Contract Pharmaceutical Manufacturing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Contract Pharmaceutical Manufacturing Product Offered

2.5 Key Companies Time to Begin Mass Production of Contract Pharmaceutical Manufacturing

2.6 Contract Pharmaceutical Manufacturing Market Competitive Analysis

2.6.1 Contract Pharmaceutical Manufacturing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Contract Pharmaceutical Manufacturing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 Injectable

3.1.3 API

3.1.4 Other

3.2 Global Contract Pharmaceutical Manufacturing Sales Value by Type

3.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Contract Pharmaceutical Manufacturing Sales Value, by Type (2019-2030)

3.2.3 Global Contract Pharmaceutical Manufacturing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Large Enterprise

4.1.2 Small Medium Enterprise

4.2 Global Contract Pharmaceutical Manufacturing Sales Value by Application

4.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Contract Pharmaceutical Manufacturing Sales Value, by Application (2019-2030)

4.2.3 Global Contract Pharmaceutical Manufacturing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Contract Pharmaceutical Manufacturing Sales Value by Region

5.1.1 Global Contract Pharmaceutical Manufacturing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Contract Pharmaceutical Manufacturing Sales Value by Region (2019-2024)

5.1.3 Global Contract Pharmaceutical Manufacturing Sales Value by Region (2025-2030)

5.1.4 Global Contract Pharmaceutical Manufacturing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

5.2.2 North America Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

5.3.2 Europe Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

5.4.2 Asia Pacific Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

5.5.2 South America Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

5.6.2 Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value

6.3 United States

6.3.1 United States Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.3.2 United States Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.4.2 Europe Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.5.2 China Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.6.2 Japan Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.7.2 South Korea Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.8.2 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Contract Pharmaceutical Manufacturing Sales Value, 2019-2030

6.9.2 India Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Contract Pharmaceutical Manufacturing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Catalent

7.1.1 Catalent Profile

7.1.2 Catalent Main Business

7.1.3 Catalent Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.1.5 Catalent Recent Developments

7.2 DPx

7.2.1 DPx Profile

7.2.2 DPx Main Business

7.2.3 DPx Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.2.4 DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.2.5 DPx Recent Developments

7.3 Lonza

7.3.1 Lonza Profile

7.3.2 Lonza Main Business

7.3.3 Lonza Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.3.5 Piramal Healthcare Recent Developments

7.4 Piramal Healthcare

7.4.1 Piramal Healthcare Profile

7.4.2 Piramal Healthcare Main Business

7.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.4.5 Piramal Healthcare Recent Developments

7.5 Aenova

7.5.1 Aenova Profile

7.5.2 Aenova Main Business

7.5.3 Aenova Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.5.5 Aenova Recent Developments

7.6 Jubilant

7.6.1 Jubilant Profile

7.6.2 Jubilant Main Business

7.6.3 Jubilant Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.6.5 Jubilant Recent Developments

7.7 Famar

7.7.1 Famar Profile

7.7.2 Famar Main Business

7.7.3 Famar Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.7.4 Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.7.5 Famar Recent Developments

7.8 Boehringer Ingelheim

7.8.1 Boehringer Ingelheim Profile

7.8.2 Boehringer Ingelheim Main Business

7.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.8.5 Boehringer Ingelheim Recent Developments

7.9 Fareva Holding

7.9.1 Fareva Holding Profile

7.9.2 Fareva Holding Main Business

7.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.9.5 Fareva Holding Recent Developments

7.10 AbbVie

7.10.1 AbbVie Profile

7.10.2 AbbVie Main Business

7.10.3 AbbVie Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.10.5 AbbVie Recent Developments

7.11 Nipro Corp

7.11.1 Nipro Corp Profile

7.11.2 Nipro Corp Main Business

7.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.11.5 Nipro Corp Recent Developments

7.12 Vetter

7.12.1 Vetter Profile

7.12.2 Vetter Main Business

7.12.3 Vetter Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.12.5 Vetter Recent Developments

7.13 Sopharma

7.13.1 Sopharma Profile

7.13.2 Sopharma Main Business

7.13.3 Sopharma Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.13.5 Sopharma Recent Developments

7.14 DPT Laboratories

7.14.1 DPT Laboratories Profile

7.14.2 DPT Laboratories Main Business

7.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.14.5 DPT Laboratories Recent Developments

7.15 Recipharm

7.15.1 Recipharm Profile

7.15.2 Recipharm Main Business

7.15.3 Recipharm Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.15.5 Recipharm Recent Developments

7.16 NextPharma

7.16.1 NextPharma Profile

7.16.2 NextPharma Main Business

7.16.3 NextPharma Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.16.5 NextPharma Recent Developments

7.17 Dishman

7.17.1 Dishman Profile

7.17.2 Dishman Main Business

7.17.3 Dishman Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.17.5 Dishman Recent Developments

7.18 Aesica

7.18.1 Aesica Profile

7.18.2 Aesica Main Business

7.18.3 Aesica Contract Pharmaceutical Manufacturing Products, Services and Solutions

7.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2019-2024)

7.18.5 Aesica Recent Developments

8 Industry Chain Analysis

8.1 Contract Pharmaceutical Manufacturing Industrial Chain

8.2 Contract Pharmaceutical Manufacturing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Contract Pharmaceutical Manufacturing Sales Model

8.5.2 Sales Channel

8.5.3 Contract Pharmaceutical Manufacturing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Contract Pharmaceutical Manufacturing Market Trends

Table 2. Contract Pharmaceutical Manufacturing Market Drivers & Opportunity

Table 3. Contract Pharmaceutical Manufacturing Market Challenges

Table 4. Contract Pharmaceutical Manufacturing Market Restraints

Table 5. Global Contract Pharmaceutical Manufacturing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Contract Pharmaceutical Manufacturing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Contract Pharmaceutical Manufacturing Product Type

Table 9. Key Companies Time to Begin Mass Production of Contract Pharmaceutical Manufacturing

Table 10. Global Contract Pharmaceutical Manufacturing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Contract Pharmaceutical Manufacturing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Contract Pharmaceutical Manufacturing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Contract Pharmaceutical Manufacturing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Contract Pharmaceutical Manufacturing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Contract Pharmaceutical Manufacturing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Contract Pharmaceutical Manufacturing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Contract Pharmaceutical Manufacturing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2019-2024) & (%)

Table 27. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value, (2025-2030) & (US$ Million)

Table 31. Catalent Basic Information List

Table 32. Catalent Description and Business Overview

Table 33. Catalent Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Catalent (2019-2024)

Table 35. Catalent Recent Developments

Table 36. DPx Basic Information List

Table 37. DPx Description and Business Overview

Table 38. DPx Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of DPx (2019-2024)

Table 40. DPx Recent Developments

Table 41. Lonza Basic Information List

Table 42. Lonza Description and Business Overview

Table 43. Lonza Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Lonza (2019-2024)

Table 45. Lonza Recent Developments

Table 46. Piramal Healthcare Basic Information List

Table 47. Piramal Healthcare Description and Business Overview

Table 48. Piramal Healthcare Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Piramal Healthcare (2019-2024)

Table 50. Piramal Healthcare Recent Developments

Table 51. Aenova Basic Information List

Table 52. Aenova Description and Business Overview

Table 53. Aenova Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Aenova (2019-2024)

Table 55. Aenova Recent Developments

Table 56. Jubilant Basic Information List

Table 57. Jubilant Description and Business Overview

Table 58. Jubilant Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Jubilant (2019-2024)

Table 60. Jubilant Recent Developments

Table 61. Famar Basic Information List

Table 62. Famar Description and Business Overview

Table 63. Famar Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Famar (2019-2024)

Table 65. Famar Recent Developments

Table 66. Boehringer Ingelheim Basic Information List

Table 67. Boehringer Ingelheim Description and Business Overview

Table 68. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Boehringer Ingelheim (2019-2024)

Table 70. Boehringer Ingelheim Recent Developments

Table 71. Fareva Holding Basic Information List

Table 72. Fareva Holding Description and Business Overview

Table 73. Fareva Holding Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Fareva Holding (2019-2024)

Table 75. Fareva Holding Recent Developments

Table 76. AbbVie Basic Information List

Table 77. AbbVie Description and Business Overview

Table 78. AbbVie Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of AbbVie (2019-2024)

Table 80. AbbVie Recent Developments

Table 81. Nipro Corp Basic Information List

Table 82. Nipro Corp Description and Business Overview

Table 83. Nipro Corp Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Nipro Corp (2019-2024)

Table 85. Nipro Corp Recent Developments

Table 86. Vetter Basic Information List

Table 87. Vetter Description and Business Overview

Table 88. Vetter Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Vetter (2019-2024)

Table 90. Vetter Recent Developments

Table 91. Sopharma Basic Information List

Table 92. Sopharma Description and Business Overview

Table 93. Sopharma Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Sopharma (2019-2024)

Table 95. Sopharma Recent Developments

Table 96. DPT Laboratories Basic Information List

Table 97. DPT Laboratories Description and Business Overview

Table 98. DPT Laboratories Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 99. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of DPT Laboratories (2019-2024)

Table 100. DPT Laboratories Recent Developments

Table 101. Recipharm Basic Information List

Table 102. Recipharm Description and Business Overview

Table 103. Recipharm Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 104. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Recipharm (2019-2024)

Table 105. Recipharm Recent Developments

Table 106. NextPharma Basic Information List

Table 107. NextPharma Description and Business Overview

Table 108. NextPharma Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 109. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of NextPharma (2019-2024)

Table 110. NextPharma Recent Developments

Table 111. Dishman Basic Information List

Table 112. Dishman Description and Business Overview

Table 113. Dishman Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 114. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Dishman (2019-2024)

Table 115. Dishman Recent Developments

Table 116. Aesica Basic Information List

Table 117. Aesica Description and Business Overview

Table 118. Aesica Contract Pharmaceutical Manufacturing Products, Services and Solutions

Table 119. Revenue (US$ Million) in Contract Pharmaceutical Manufacturing Business of Aesica (2019-2024)

Table 120. Aesica Recent Developments

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Contract Pharmaceutical Manufacturing Downstream Customers

Table 124. Contract Pharmaceutical Manufacturing Distributors List

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Contract Pharmaceutical Manufacturing Product Picture

Figure 2. Global Contract Pharmaceutical Manufacturing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 4. Contract Pharmaceutical Manufacturing Report Years Considered

Figure 5. Global Contract Pharmaceutical Manufacturing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Contract Pharmaceutical Manufacturing Revenue in 2023

Figure 7. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Oral Picture

Figure 9. Injectable Picture

Figure 10. API Picture

Figure 11. Other Picture

Figure 12. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Contract Pharmaceutical Manufacturing Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Large Enterprise

Figure 15. Product Picture of Small Medium Enterprise

Figure 16. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Contract Pharmaceutical Manufacturing Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Contract Pharmaceutical Manufacturing Sales Value (%), (2019-2030)

Figure 29. United States Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 35. China Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 37. China Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 47. India Contract Pharmaceutical Manufacturing Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Contract Pharmaceutical Manufacturing Sales Value by Type (%), 2023 VS 2030

Figure 49. India Contract Pharmaceutical Manufacturing Sales Value by Application (%), 2023 VS 2030

Figure 50. Contract Pharmaceutical Manufacturing Industrial Chain

Figure 51. Contract Pharmaceutical Manufacturing Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global NDT Ultrasonic Scanner Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17O11515

Tue May 07 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Prepacked Chromatography Columns Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0R11279

Tue May 07 00:00:00 UTC 2024

Add to Cart

Global Pharma Freeze-drying System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34I11245

Tue May 07 00:00:00 UTC 2024

Add to Cart

Global Drug Molecule Block Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1R11709

Tue May 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions